Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-16-Speech-3-191-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110216.11.3-191-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"I voted in favour of this resolution, in which the European Parliament expresses its position on the directive on the prevention of the entry into the legal supply chain of medicinal products which are falsified. We must take into account the concern expressed by EU citizens over the quality and safety of the medicinal products they are consuming. All the more so given that experts are observing alarming tendencies: a sharp increase in seizures of falsified medicines by customs (an increase of up to 384% since 2005); a trend towards the falsification of life-saving medicines, which can have fatal consequences; counterfeit medicines are increasingly being found in legal supply chains. EU citizens must be very careful when purchasing medicines online, because here the chances of acquiring falsified medicines increases by up to 50%. Patients need to be absolutely sure that the medicines they consume really are the medicines they expect them to be. The EU must therefore react swiftly and constructively to the dangerous tendencies mentioned. This directive is a first step towards ensuring that only high quality medicines are distributed in the EU. To achieve this objective I feel that it is very important to establish strict controls and determine responsibility at all levels of manufacturing, distribution and sales. Then EU citizens will feel safe when using genuinely high quality medicines."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples